Innovation and Beauty: The Role of Regenerative Medicine and Neurotoxins
Tuesday, May 20, 2025
9:15 AM – 10:15 AM
CE: 1.00 AAPA Category 1 CME
No relevant relationships with ineligible companies to disclose within the past 24 months.
This session explores the rapid growth of aesthetic medicine, spotlighting neurotoxins and regenerative biotechnology as essential components shaping modern practices. With expanding applications, neurotoxins play a central role in non-surgical facial rejuvenation, catering to the rising demand for minimally invasive procedures. Attendees will gain foundational knowledge about neurotoxin products, their unique properties, and the science supporting their use, empowering them to inform patients and make evidence-based decisions in their practice. In addition, the session introduces the revolutionary field of regenerative aesthetics, where innovative techniques—like biostimulators, stem cell therapy, and growth factor treatments—are advancing anti-aging and skin rejuvenation. Attendees will explore the scientific basis and applications of these cutting-edge therapies and examine how biotechnology is redefining beauty standards by offering new, natural methods for achieving youthful skin. Emphasizing the importance of continuing education, this presentation provides a comprehensive view of how neurotoxins and regenerative methods are transforming the aesthetics industry.
Learning Objectives:
At the conclusion of this session, participants should be able to:
Outline the products, properties, use, and safety considerations of neurotoxins in aesthetic medicine
Recognize the FDA-approved indications for neurotoxin treatments in aesthetic medicine, such as glabellar lines, forehead lines, and crow's feet, as well as other potential off-label uses
Describe technologies underpinning regenerative aesthetics, the clinical applications, benefits, and outcomes of regenerative aesthetic treatments, supported by evidence-based research
